Measuring Medication Adherence in Pediatric Cancer: An Approach to Validation
Open Access
- 16 May 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Pediatric Psychology
- Vol. 42 (2) , 232-244
Abstract
Objective This study described the prospective relationship between pharmacological and behavioral measures of 6-mercaptopurine (6MP) medication adherence in a multisite cohort of pediatric patients diagnosed with cancer (N = 139). Methods Pharmacological measures (i.e., metabolite concentrations) assessed 6MP intake. Behavioral measures (e.g., electronic monitoring) described adherence patterns over time. Results Three metabolite profiles were identified across 15 months: one group demonstrated low levels of both metabolites (40.8%) consistent with nonadherence and/or suboptimal therapy; two other groups demonstrated metabolite clusters indicative of adequate adherence (59.2%). Those patients whose metabolite profile demonstrated low levels of both metabolites had consistently lower behavioral adherence rates. Conclusions To our knowledge, this was the first study to prospectively validate a pharmacological measure of medication adherence with a behavioral adherence measure in a relatively large sample of pediatric patients with cancer. Using multiple methods of adherence measurement could inform clinical care and target patients in need of intervention.Keywords
Funding Information
- National Institutes of Health (1F31CA168307, 1R01CA119162)
- National Cancer Institute
- National Center for Advancing Translational Sciences (UL1TR000003)
- National Center for Research Resources (UL1RR024134)
- NIH
This publication has 20 references indexed in Scilit:
- Electronic Monitoring of Medication Adherence in Early Maintenance Phase Treatment for Pediatric Leukemia and Lymphoma: Identifying Patterns of NonadherenceJournal of Pediatric Psychology, 2013
- Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- Electronic Measurement of Medication Adherence in Pediatric Chronic Illness: A Review of MeasuresThe Journal of Pediatrics, 2011
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine DosingClinical Pharmacology & Therapeutics, 2011
- The development of an objective methodology to measure medication adherence to oral thiopurines in paediatric patients with acute lymphoblastic leukaemia—an exploratory studyEuropean Journal of Clinical Pharmacology, 2009
- A Video Game Improves Behavioral Outcomes in Adolescents and Young Adults With Cancer: A Randomized TrialPediatrics, 2008
- How low is too low? Use of cluster analysis to define low levels of mercaptopurine metabolitesPediatric Blood & Cancer, 2005
- Modeling and simulation of adherence: Approaches and applications in therapeuticsThe AAPS Journal, 2005
- Compliance with oral chemotherapy in childhood lymphoblastic leukaemiaCancer Treatment Reviews, 1995
- Mercaptopurine metabolism and risk of relapse in childhood lymphoblastic leukaemiaThe Lancet, 1994